These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17651258)

  • 1. Regression of choroidal metastasis from breast carcinoma following Letrozole therapy.
    Venkatesh P; Garg S
    Clin Exp Ophthalmol; 2007 Jul; 35(5):492-4. PubMed ID: 17651258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choroidal metastasis in a patient with disseminated breast cancer: hormonal therapy-induced regression.
    El-Saify WM
    Breast J; 2006; 12(5):490-2. PubMed ID: 16958973
    [No Abstract]   [Full Text] [Related]  

  • 3. Regression of choroidal metastases from breast carcinoma using aromatase inhibitors.
    Manquez ME; Shields CL; Karatza EC; Shields JA
    Br J Ophthalmol; 2005 Jun; 89(6):776-7. PubMed ID: 15923523
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of prolonged disease-free survival in a patient with choroidal metastasis from breast cancer.
    Jang RW; Doherty M; Hopkins JJ; Warner E
    Nat Clin Pract Oncol; 2009 Feb; 6(2):118-21. PubMed ID: 19065141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.
    Barnadas A; Estévez LG; Lluch-Hernández A; Rodriguez-Lescure A; Rodriguez-Sanchez C; Sanchez-Rovira P
    Adv Ther; 2011 Dec; 28(12):1045-58. PubMed ID: 22068628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic chemotherapy and tamoxifen induced regression of choroidal metastasis from a breast carcinoma in a male.
    Shome D; Jayadev C; Gadgil D; Natarajan S; Jain V
    Indian J Ophthalmol; 2007; 55(6):475-7. PubMed ID: 17951913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring.
    Thomas JS; Julian HS; Green RV; Cameron DA; Dixon MJ
    Histopathology; 2007 Aug; 51(2):219-26. PubMed ID: 17650216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine metastasis of lobular breast cancer during adjuvant letrozole therapy.
    Komeda S; Furukawa N; Kasai T; Washida A; Kobayashi H
    J Obstet Gynaecol; 2013 Jan; 33(1):99-101. PubMed ID: 23259900
    [No Abstract]   [Full Text] [Related]  

  • 9. Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection.
    Ozdogan M; Samur M; Bozcuk HS; Sagtas E; Yildiz M; Artac M; Savas B
    Jpn J Clin Oncol; 2003 May; 33(5):229-31. PubMed ID: 12865466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huge response to letrozole in inoperable T4 breast cancer: a case report.
    Di Cosimo S; Altomare V; Ferretti G; Gravante G; Rabitti C; Rea F; Arullani A; D'Aprile M
    Clin Ter; 2001; 152(4):263-5. PubMed ID: 11725620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual macular degeneration following breast cancer.
    Margolis R; Budd GT; Singh AD
    Acta Ophthalmol Scand; 2007 Sep; 85(6):686-7. PubMed ID: 17335515
    [No Abstract]   [Full Text] [Related]  

  • 12. Late distant recurrence of breast carcinoma and metastasis to the main bronchus and choroid: A case report.
    Luo Z; Cai Q; Zhao Y; Wang X; Fu S; Zhai L
    Medicine (Baltimore); 2018 May; 97(20):e10754. PubMed ID: 29768356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Choroidal metastasis from a breast carcinoma. Diagnosis and follow-up with optical coherence tomography and fluorescein angiography and autofluorescence with HRA-II (Heidelberg Retina Angiograph)].
    Pérez-Alvarez MJ; Arriola-Villalobos P; Reche-Frutos J; García-Sánchez J
    Arch Soc Esp Oftalmol; 2009 May; 84(5):267-70. PubMed ID: 19466689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
    Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547
    [No Abstract]   [Full Text] [Related]  

  • 15. [The ATAC study on adjuvants in breast cancer].
    Bravi S
    Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
    [No Abstract]   [Full Text] [Related]  

  • 16. Letrozole: advancing hormone therapy in breast cancer.
    Lee RJ; Armstrong AC; Wardley AM
    Womens Health (Lond); 2012 Nov; 8(6):611-8. PubMed ID: 23181527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole as adjuvant therapy for postmenopausal women with early breast cancer.
    Russell CA
    Manag Care Interface; 2007 Sep; 20(9):30-1, 36. PubMed ID: 18161388
    [No Abstract]   [Full Text] [Related]  

  • 19. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: the example of clinical studies].
    Giannessi PG
    Suppl Tumori; 2004; 3(4):S73-4. PubMed ID: 15206218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].
    Kahán Z
    Magy Onkol; 2008 Jun; 52(2):225-6. PubMed ID: 18640899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.